SEARCH RESULTS FOR: "Tag: BIIB"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2023(1)
2022(9)
2021(7)
2020(4)
2019(15)
2018(7)
2017(14)
2016(14)
2015(15)
2014(1)
CATEGORIES
5-Minute Market Rundown(4)
Analyst Update(12)
Analyst Upgrades(3)
Buzz Stocks(35)
By the Numbers(2)
Earnings Preview(3)
Ezines(2)
General(5)
Intraday Option Activity(14)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(10)
Technical Analysis(1)
The Week Ahead(1)

1/20/2023 11:15 AM
The U.S. Food and Drug Administration (FDA) rejected the accelerated approval of Eli Lilly and Co's (NYSE:LLY) experimental Alzheimer's drug due to a lack of enough trial data from patients treated f...
12/29/2022 2:49 PM
Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today. Biogen Inc (NASDAQ:BIIB), Crispr Therapeutics AG (NASDAQ:CRSP), and also Vertex Pharmaceuticals Incorporated ...
11/28/2022 9:37 AM
Biogen Inc (NASDAQ:BIIB) is under pressure this morning, in the wake of a research paper published on Science.org this Sunday. The report indicated a 65-year-old patient receiving the experimental Al...
11/21/2022 10:49 AM
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is down 2.1% at $8.54 at last check, after the company named former Novartis (NVS) and Biogen (BIIB) executive Richard Francis as its new chief execu...
11/14/2022 10:57 AM
While several sectors are taking a breather this morning, Biogen Inc (NASDAQ:BIIB) is climbing after major competitor Roche (ROG) said that its Alzheimer's drug candidate, gantenerumab, failed to me...